| 30th Nov 2018 3:20 pm |
RNS |
Form 8.3 - Shire plc |
| 30th Nov 2018 3:18 pm |
EQS |
Form 8.3 - The Vanguard Group, Inc.: Shire plc |
| 30th Nov 2018 3:17 pm |
RNS |
Form 8.3 - Takeda Pharmaceutical Company Limited |
| 30th Nov 2018 3:06 pm |
RNS |
Form 8.3 - Shire Plc |
| 30th Nov 2018 3:03 pm |
RNS |
Form 8.5 (EPT/NON-RI) |
| 30th Nov 2018 3:03 pm |
BUS |
Form 8.3 - SHIRE PLC - AMENDMENT |
| 30th Nov 2018 3:00 pm |
BUS |
Form 8.3 - Shire PLC |
| 30th Nov 2018 2:57 pm |
BUS |
Form 8.3 - SHIRE PLC AMENDMENT |
| 30th Nov 2018 2:56 pm |
RNS |
Form 8.5 (EPT/NON-RI) |
| 30th Nov 2018 2:54 pm |
RNS |
Form 8.3 - [Shire Plc] |
| 30th Nov 2018 2:34 pm |
BUS |
Form 8.3 - SHIRE PLC - Amendment |
| 30th Nov 2018 2:32 pm |
RNS |
Form 8.3 - Takeda Pharmaceutical Company Limited |
| 30th Nov 2018 2:28 pm |
RNS |
Form 8.3 - Shire Plc |
| 30th Nov 2018 2:16 pm |
RNS |
Form 8.3 - Takeda Pharmaceutical Company Limited |
| 30th Nov 2018 2:15 pm |
RNS |
Form 8.3 - Shire plc |
| 30th Nov 2018 1:54 pm |
RNS |
Form 8.5 (EPT/RI) - Replacement of SHIRE |
| 30th Nov 2018 1:51 pm |
RNS |
Form 8.5 (EPT/RI) - Replacement of SHIRE |
| 30th Nov 2018 1:45 pm |
RNS |
Form 8.3 - Takeda Pharmaceutical |
| 30th Nov 2018 1:44 pm |
RNS |
Form 8.3 - Shire plc |
| 30th Nov 2018 1:39 pm |
RNS |
Form 8.5 (EPT/RI) - Replacement of SHIRE |
| 30th Nov 2018 1:36 pm |
RNS |
Form 8.5 (EPT/RI) - Replacement of SHIRE |
| 30th Nov 2018 1:05 pm |
BUS |
Form 8.3 - SHIRE PLC |
| 30th Nov 2018 11:57 am |
RNS |
Form 8.3 - Shire Plc |
| 30th Nov 2018 11:57 am |
BUS |
Form 8.3 - SHIRE PLC - Amendment |
| 30th Nov 2018 11:37 am |
RNS |
Form 8.5 (EPT/NON-RI)- Shire Plc |
| 30th Nov 2018 11:20 am |
RNS |
Form 8.5 (EPT/RI) - SHIRE PLC |
| 30th Nov 2018 11:19 am |
RNS |
Form 8.5 (EPT/RI) - SHIRE PLC |
| 30th Nov 2018 11:18 am |
RNS |
Form 8.5 (EPT/RI) - SHIRE PLC |
| 30th Nov 2018 11:12 am |
RNS |
Form 8.5 - Shire Plc |
| 30th Nov 2018 11:04 am |
RNS |
Form 8.5 (EPT/NON-RI) - SHIRE PLC |
| 30th Nov 2018 10:58 am |
RNS |
Form 8.3 - Takeda Pharmaceutical Company Limited |
| 30th Nov 2018 10:36 am |
RNS |
Form 8.5 (EPT/RI)- Shire plc |
| 30th Nov 2018 10:32 am |
RNS |
Form 8.5 (EPT/RI) |
| 30th Nov 2018 10:16 am |
RNS |
Form 8.5 (EPT/RI) |
| 30th Nov 2018 10:14 am |
RNS |
Form 8.5 (EPT/NON-RI) |
| 30th Nov 2018 7:19 am |
RNS |
Form 8.3 - Shire plc |
| 30th Nov 2018 7:00 am |
RNS |
Form 8.3 - Takeda Pharmaceutical Company Limited |
| 30th Nov 2018 7:00 am |
RNS |
Form 8.3 - Shire Plc |
| 30th Nov 2018 7:00 am |
RNS |
Form 8.3 - Shire PLC |
| 30th Nov 2018 7:00 am |
GNW |
Shire Receives European Approval for TAKHZYRO™ (lanadelumab) subcutaneous injection, for the Preventive Treatment of Hereditary Angioedema |
